Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial

Steroid-dependent nephrotic syndrome (SDNS) carries a high risk of toxicity from steroids or steroid-sparing agents. This open-label, noninferiority, randomized controlled trial at four sites in Italy tested whether rituximab is noninferior to steroids in maintaining remission in juvenile SDNS. We e...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Am Soc Nephrol
Main Authors: Ravani, Pietro, Rossi, Roberta, Bonanni, Alice, Quinn, Robert R., Sica, Felice, Bodria, Monica, Pasini, Andrea, Montini, Giovanni, Edefonti, Alberto, Belingheri, Mirco, De Giovanni, Donatella, Barbano, Giancarlo, Degl’Innocenti, Ludovica, Scolari, Francesco, Murer, Luisa, Reiser, Jochen, Fornoni, Alessia, Ghiggeri, Gian Marco
Format: Artigo
Jezik:Inglês
Izdano: American Society of Nephrology 2015
Teme:
Clinical Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4552120/
https://ncbi.nlm.nih.gov/pubmed/25592855
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2014080799
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki